Amylyx Pharmaceuticals Inc share price logo

Amylyx Pharmaceuticals Inc Share Price

NASDAQ: AMLX

Mid Cap

$17.55

-0.02

(-0.09%)

as on

Amylyx Pharmaceuticals Inc Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $17.16
    $17.76
    downward going graph

    2.22%

    Downside

    1.20%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.94
    $18.61
    downward going graph

    77.55%

    Downside

    6.01%

    Upside

    downward going graph

Amylyx Pharmaceuticals Inc share price movements today

Previous Close
$17.57
Open
$17.56
Volume
750.2K
Day's Low - High
$17.16 - $17.76
52 Week Low - High
$3.94 - $18.61

Amylyx Pharmaceuticals Inc Historical Returns

1 Month Return
+ 27.23 %
3 Month Return
+ 3.84 %
1 Year Return
+ 315.37 %
3 Year Return
-43.41 %
5 Year Return
0 %

Amylyx Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Amylyx Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-1.305

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-152.8M

Revenue (TTM)

-665.0K

Profit Margin

0.00%

Return On Equity TTM

-61.59%

Amylyx Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.0BNANA0.00%
BUY$25.1BNA20.5741.94%
HOLD$17.1B11.8%NA-24.58%
BUY$43.1BNA19.3615.11%
BUY$51.8B-27.88%20.3528.24%

Stock Returns calculator for Amylyx Pharmaceuticals Inc Stock including INR - Dollar returns

The Amylyx Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Amylyx Pharmaceuticals Inc investment value today

Current value as on today

₹4,55,443

Returns

₹3,55,443

(+355.44%)

Returns from Amylyx Pharmaceuticals Inc Stock

₹3,14,894 (+314.89%)

Dollar Impact

₹40,549 (+40.55%)

Analyst Recommendation on Amylyx Pharmaceuticals Inc Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals Inc. Average target price of $22.8

Amylyx Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals Inc.

What analysts predicted

23.03%UPSIDE

Target Price

$22.8

Current Price

$17.55

Analyzed by

13 Analysts

Target

$22.80

Amylyx Pharmaceuticals Inc target price $22.8, a slight upside of 23.03% compared to current price of $17.55. According to 13 analysts rating.

Amylyx Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Amylyx Pharmaceuticals Inc Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

Amylyx Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
102
108
88
-1
0
0
-
-
-
-
Gross Profit
97
99
-27
-8
0
0
-
0
-19
0
Operating Income
18
1
-122
-53
-75
-40
-37
-42
-36
-36
EBITDA
19
2
-121
-53
-75
-40
-37
-41
-34
-30
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
22
6
-118
-72
-72
-38
-35
-41
-34
-32
Income Tax Expense
1
1
0
-
-72
0
-
-
-
0
Net Income
20
4
-118
-72
-72
-37
-35
-41
-34
-32
Net Profit Margin
20.35%
4.36%
-134.01%
7106.55%
-17476.92%
5646.02%
0.00%
0.00%
0.00%
0.00%

Amylyx Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
0
22
380
87
-
Gross Profit
-10
-23
0
19
355
45
0
Operating Income
-13
-39
-82
-201
38
-314
-153
EBITDA
1
-39
-82
-200
39
-290
-144
Interest Expense
1
2
0
4
-
-
-
Depreciation
-
0
0
0
1
0
0
Income Before Tax
-13
-42
-87
-197
54
-302
-144
Income Tax Expense
1
2
0
0
5
0
0
Net Income
-14
-42
-87
-198
49
-301
-144
Net Profit Margin
-1038.99%
-6504.62%
-30834.74%
-892.38%
12.94%
-345.36%
0.00%

Amylyx Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
4
-118
-72
-72
-37
-35
-41
-34
-32
Operating Cash Flow
13
0
-66
-41
-59
-39
-25
-30
-27
Investing Cash Flow
20
0
-28
38
64
-43
22
5
29
Financing Cash Flow
0
0
0
0
0
65
0
191
0
Change in Cash
34
0
-95
-2
5
-17
-1
167
1

Amylyx Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-42
-87
-198
49
-301
-144
Operating Cash Flow
-36
-74
-179
11
-167
-123
Investing Cash Flow
0
-46
-238
92
75
14
Financing Cash Flow
46
158
431
3
0
257
Change in Cash
9
37
12
107
-92
148

Global Institutional Holdings in Amylyx Pharmaceuticals Inc

Funds
Holdings
Great Point Partners LLC
1.54%
Almitas Capital LLC
1.92%
Morgan Stanley - Brokerage Accounts
1.76%
HHG PLC
2.29%
683 Capital Management LLC
1.6%

Insights on Amylyx Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, AMLX stock has moved up by 315.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -41.44M → -32.99M (in $), with an average increase of 12.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 148.5% return, outperforming this stock by 191.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter

About Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
OrganisationAmylyx Pharmaceuticals Inc
Headquarters55 Cambridge Parkway, Cambridge, MA, United States, 02142
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joshua B. Cohen
E-voting on sharesClick here to vote

Key Management of Amylyx Pharmaceuticals Inc

Name

Title

Dr. Machelle Manuel Ph.D.

VP & Head of Global Medical Affairs

Mr. James M. Frates M.B.A.

Chief Financial Officer

Mr. Tom Holmes

Chief Technical Operations Officer

Ms. Linda A. Arsenault

Chief Human Resources Officer

Ms. Tammy Sarnelli

Global Head of Regulatory Affairs

Dr. Jamie Timmons

Head of Global Medical Strategy & Communications

Mr. Joshua B. Cohen

Co-Founder, Co-CEO & Director

Mr. Justin B. Klee

Co-Founder, Co-CEO & Director

Ms. Gina M. Mazzariello J.D.

Chief Legal Officer & General Counsel

Ms. Lindsey Allen

Head of Investor Relations & Communications

FAQs

What is Amylyx Pharmaceuticals Inc share price today?

Amylyx Pharmaceuticals Inc share price today is $17.55 as on at the close of the market. Amylyx Pharmaceuticals Inc share today touched a day high of $17.76 and a low of $17.16.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals Inc share?

Amylyx Pharmaceuticals Inc share touched a 52 week high of $18.61 on and a 52 week low of $3.94 on . Amylyx Pharmaceuticals Inc stock price today i.e. is closed at $17.55,which is 5.67% down from its 52 week high and 345.43% up from its 52 week low.

What is Amylyx Pharmaceuticals Inc's market capitalisation today?

Amylyx Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Amylyx Pharmaceuticals Inc Stock (AMLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amylyx Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals Inc Shares that will get you 0.0855 shares as per Amylyx Pharmaceuticals Inc share price of $17.55 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals Inc Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals Inc (AMLX) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Amylyx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Amylyx Pharmaceuticals Inc share’s latest price of $17.55 as on April 22, 2026 at 1:29 am IST, you will get 0.5698 shares of Amylyx Pharmaceuticals Inc. Learn more about fractional shares .